Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Sphaera Pharma
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

SPHAERA PHARMA PRIVATE LIMITED

All Companies ›

Delhi ›

Manufacturing of Chemical Products ›

Active

Updated: 14 Dec 2025

Sphaera Pharma Private Limited, is an unlisted private company incorporated on 30 November, 2007. It is classified as a private limited company and is located in , Delhi. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 9.25 cr.

Sphaera Pharma's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2020. It's EBITDA has decreased by 67.95% over the previous year. At the same time, it's book networth has increased by 8.25%.

Subscription Plans

Industry and products

Manufacturing of Pharmaceuticals

Scientific research and development

Company size

Auth Capital

₹ 10.0 Cr

Paidup Capital

₹ 9.2 Cr

Revenue

Not Available

Key Metrics

** All rupee values in INR lacs.

Total Revenue

76.27%

₹ GET PRO

EBITDA

-67.95%

₹ GET PRO

Net Profit

278.53%

₹ GET PRO

Networth

8.25%

₹ GET PRO

Borrowings

₹ GET PRO

Assets

2.07%

₹ GET PRO

Gross Margin

-20.64

GET PRO %

Operating Margin

-9.43

GET PRO %

Net Profit Margin

3.47

GET PRO %

Return on Equity

5.44

GET PRO %

ROCE

-6.23

GET PRO %

Debt to Equity

GET PRO

Sales

Mar 2020

Net worth

Mar 2020

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (2)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Abhinav Dhandia	00456720	7 years
Director	Ashish Dugar	09810264	3 years
Director	Somdutta Sen	09202044	3 years

Financial Highlights

** All numbers in INR lacs

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR lacs

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	924.8	924.8	924.8	924.8	924.8
Reserves	24.5	-62.8	-363.6	-350.1	-303.6
Borrowings +	-	-	-	-	-
Long term borrowings	-	-	-	-	-
Short term borrowings	-	-	-	-	-
Trade payables +	44.6	52.4	54.5	69.8	15.0
Days payable	208.0	180.0	181.0	869.0	29.0
Other liabilities +	418.5	80.5	88.2	106.2	72.8
Other non-current liabilities	16.2	16.0	18.7	20.9	21.7
Other current liabilities	357.7	12.0	14.9	15.5	36.2
Total liabilities	1,367.8	942.5	649.4	680.9	694.0
Fixed Assets +	383.1	244.3	127.8	92.8	89.4
Tangible assets	252.0	178.4	127.5	92.5	89.2
CWIP	-	-	-	-	-
Intangible assets	131.1	65.9	0.3	0.3	0.3
LT loans and advances	402.0	392.9	392.3	392.2	392.2
Other non-current assets	-	-	-	0.9	-
Current assets +	582.7	305.3	129.3	194.9	212.3
Inventories	-	-	-	-	-
Trade receivables	3.5	21.3	9.7	131.4	35.6
Cash and cash equivalents	459.3	214.4	10.2	8.8	62.5
ST loans and advances	118.4	69.2	109.2	53.3	105.3
Other current assets	1.4	0.4	0.3	1.4	8.8
Total assets	1,367.8	942.5	649.4	680.9	694.0

Percentage of assets	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	67.61	98.12	142.41	135.82	133.25
Reserves	1.79	-6.66	-55.99	-51.42	-43.75
Borrowings +	0.0	0.0	0.0	0.0	0.0
Long term borrowings	0.0	0.0	0.0	0.0	0.0
Short term borrowings	0.0	0.0	0.0	0.0	0.0
Trade payables	3.26	5.56	8.4	10.26	2.16
Other liabilities +	30.6	8.54	13.58	15.6	10.5
Other non-current liabilities	1.18	1.7	2.88	3.06	3.13
Other current liabilities	26.15	1.27	2.3	2.28	5.21
Total liabilities
Fixed Assets +	28.01	25.92	19.68	13.63	12.89
Tangible assets	18.42	18.92	19.64	13.59	12.85
CWIP	0.0	0.0	0.0	0.0	0.0
Intangible assets	9.58	7.0	0.04	0.04	0.04
LT loans and advances	29.39	41.69	60.42	57.61	56.52
Other non-current assets	0.0	0.0	0.0	0.14	0.0
Current assets +	42.6	32.39	19.91	28.63	30.59
Inventories	0.0	0.0	0.0	0.0	0.0
Trade receivables	0.26	2.26	1.49	19.3	5.14
Cash and cash equivalents	33.58	22.75	1.56	1.3	9.01
ST loans and advances	8.66	7.34	16.81	7.82	15.17
Other current assets	0.1	0.04	0.04	0.21	1.27
Total assets

Total assets

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
CYRO HEALTHCARE PRIVATE LIMITED	Active	3.8 Cr	1	Delhi
MUSKAN GREENS AND EMU FARMS PRIVATE LIMITED	Strike Off	5.0 L	1	Rajasthan
JEMPORE SOLUTIONS PRIVATE LIMITED	Strike Off	6.0 L	1	Delhi
STERLING GREEN HOMES PRIVATE LIMITED	Active	1.0 L	1	Rajasthan
DHANDIA JEWELLERS LLP	Active	50.0 L	1	Delhi
SPHAERA PHARMA RESEARCH AND DEVELOPMENT PRIVATE LIMITED	Active	1.9 L	2	Delhi
ADVANTIUM INFRASTRUCTURE PRIVATE LIMITED	Active	23.5 Cr	1	Rajasthan

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

U24232DL2007PTC224934

PAN

AALCS3747G

Incorporation

2007, 18.1 years

Company Email

info@sphaerapharma.com

Paid up Capital

₹ 9.2 Cr

Authorised Capital

₹ 10.0 Cr

AGM

Sep 2024

Type

Private

Others

FAQ - SPHAERA PHARMA PRIVATE LIMITED

What is the incorporation date of SPHAERA PHARMA PRIVATE LIMITED?

The incorporation date of SPHAERA PHARMA PRIVATE LIMITED is 30 November, 2007

What is the authorized share capital of SPHAERA PHARMA PRIVATE LIMITED?

The authorized share capital of SPHAERA PHARMA PRIVATE LIMITED is INR ₹ 10.0 Cr.

What is the paid-up capital of SPHAERA PHARMA PRIVATE LIMITED?

The paid-up capital of SPHAERA PHARMA PRIVATE LIMITED is INR ₹ 9.2 Cr.

What is the registered address of SPHAERA PHARMA PRIVATE LIMITED?

The registered address of SPHAERA PHARMA PRIVATE LIMITED is Office No.1A,2,3,6,7-A, 2nd floor, Indure House, Savitri Cinema Complex,Greater Kailash II New Delhi, Greater Kailash, South Delhi, New Delhi, Delhi, India, 110048 - 110048

What is the CIN number of SPHAERA PHARMA PRIVATE LIMITED?

The CIN number of SPHAERA PHARMA PRIVATE LIMITED is U24232DL2007PTC224934.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

SPHAERA PHARMA PRIVATE LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Company Network